AstraZeneca Earnings, Revenue beat In Q1

  • Investing.com
AstraZeneca Earnings, Revenue beat In Q1
Credit: © Reuters.

Investing.com - AstraZeneca (LON: AZN ) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.

AstraZeneca announced earnings per share of $1.89 on revenue of $11.39B. Analysts polled by Investing.com anticipated EPS of $1.65 on revenue of $10.74B.

AstraZeneca shares are up 22% from the beginning of the year and are trading at $10,630.0 , down-from-52-week-high.They are outperforming the FTSE 100 which is up 2.2% from the start of the year.

AstraZeneca shares gained 0.64% in intra-day trade the report.

AstraZeneca follows other major Healthcare sector earnings this month

AstraZeneca's report follows an earnings beat by GlaxoSmithKline on Wednesday, who reported EPS of $0.328 on revenue of $9.78B, compared to forecasts EPS of $0.2902 on revenue of $8.95B.

Oxford BioMedica had missed expectations on Wednesday, April 20, 2022 with first quarter EPS of $0.01 on revenue of $61.55M, compared to forecast for EPS of $7.80 on revenue of $77.28M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100